News

QuantumScape Inks Strategic Multi-Year Agreement With Fluence

American City Business Journals

Emergent BioSolutions founder and chairman to retire after 23 years

Fuad El-Hibri, the founder and executive chairman of Emergent BioSolutions (NYSE: EBS) is retiring 23 years after he founded the Gaithersburg biotech. Emergent, which made its name selling anthrax vaccines to the U.S. government, has been in the news much more during the coronavirus pandemic for its Covid-19 vaccine efforts, which floundered due to manufacturing issues at its Baltimore facility. El-Hibri founded the company, then called BioPort, in 1998, and served as its CEO until 2012, when he stepped into the executive chairman role.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News